Portal de Periódicos da CAPES

Tsukamurella paurometabolum: A Novel Pathogen Causing Catheter-Related Bacteremia in Patients with Cancer

1992; Oxford University Press; Volume: 14; Issue: 1 Linguagem: Inglês

10.1093/clinids/14.1.200

1537-6591

Charles L. Shapiro, Rachel Haft, Nelson M. Gantz, Gary V. Doern, John C. Christenson, Richard O’Brien, James C. Overall, B. A. Brown, Richard J. Wallace,

Actinomycetales infections and treatment

Journal Article Tsukamurella paurometabolum: A Novel Pathogen Causing Catheter-Related Bacteremia in Patients with Cancer Get access Charles L. Shapiro, Charles L. Shapiro From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Reprints or correspondence: Dr. Charles L. Shapiro, Dana-Farber Cancer Institute. 44 Binney Street, Boston, Massachusetts 02115. Search for other works by this author on: Oxford Academic PubMed Google Scholar Rachel F. Haft, Rachel F. Haft From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Nelson M. Gantz, Nelson M. Gantz From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Gary V. Doern, Gary V. Doern From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar John C. Christenson, John C. Christenson From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Richard O'Brien, Richard O'Brien From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar James C. Overall, James C. Overall From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Barbara A. Brown, Barbara A. Brown From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Richard J. Wallace, Jr. Richard J. Wallace, Jr. From the Division of Clinical Oncology, Dana-Farber Cancer Institute, and the Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts; the Division of Infectious Disease and the Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester, Massachusetts; the Division of Pediatric Infectious Diseases and the Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah; and the Department of Microbiology, University of Texas Health Science Center, Tyler, Texas Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, Volume 14, Issue 1, January 1992, Pages 200–203, https://doi.org/10.1093/clinids/14.1.200 Published: 01 January 1992 Article history Received: 28 January 1991 Revision received: 02 May 1991 Published: 01 January 1992